Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.36), $0.02 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $158.8 million versus the consensus estimate of $153.33 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.